Berotralstat


CAS No. : 1809010-50-1

(Synonyms: BCX7353)

1809010-50-1
Price and Availability of CAS No. : 1809010-50-1
Size Price Stock
1mg $420 In-stock
5mg $1250 In-stock
10mg $2000 In-stock
50 mg Get quote
100 mg Get quote
We match the lowest price on market.

We offer a substantial discount on larger orders, please inquire via [email protected]

or Fax: (86)21-58955996

Inquiry for price and availability only. Please place your order via our email or fax.

Cat. No. : HY-109127
M.Wt: 562.56
Formula: C30H26F4N6O
Purity: >98 %
Solubility: DMSO : 100 mg/mL (ultrasonic)
Introduction of 1809010-50-1 :

Berotralstat (BCX7353) is an orally active plasma kallikrein inhibitor. Berotralstat can reduce brain edema and is being studied for glioblastoma and hereditary angioedema[1][2]. IC50 & Target:Plasma kallikrein[1] In Vitro:Berotralstat inhibits the activity of kallikrein, reduces the generation of kinin, thereby blocking kinin-mediated increased vascular permeability and edema formation. Berotralstat inhibits the proliferation and migration of glioblastoma cells[2]. In Vivo:Berotralstat reduces peritumoral edema in glioblastoma (GB), reduces the frequency of angioedema attacks in case of hereditary angioedema (HAE), but causes side effects such as gastrointestinal symptoms[3].
Berotralstat (8 μM, single dose) inhibits plasma kallikrein activity and reduces contact pathway-initiated thrombin generation in F12+/+ or F12-/- mouse models[4].

Your information is safe with us.